| Mia Miller, | |
|
550 W Burnsville Pkwy Ste 201, Burnsville, MN 55337-2504 | |
| (605) 274-0217 | |
| Not Available |
| Full Name | Mia Miller |
|---|---|
| Gender | Female |
| Speciality | Surgery |
| Location | 550 W Burnsville Pkwy Ste 201, Burnsville, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598151474 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 67267 (Minnesota) | Secondary |
| 208600000X | Surgery | 67267 (Minnesota) | Primary |
| Entity Name | Physicians Vein Clinics Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720370133 PECOS PAC ID: 9638356876 Enrollment ID: O20191016000206 |
News Archive
Massachusetts General Hospital investigators have found the probable mechanism underlying a previously described biomarker associated with the risk of developing serious diseases ranging from cancer to cardiovascular disease and the risk of serious complications. In a paper published in the American Journal of Hematology, the research team reports finding that higher levels of a measure routinely taken as part of the complete blood count - the extent of variation in the size of red blood cells - is caused by reduced clearance of aging cells from the bloodstream.
Long-term immunosuppressive therapy can cause the hepatitis B virus (HBV) to become active, even in patients who are not aware that they are infected with the virus. A new guideline from the American Gastroenterological Association provides guidance to physicians and patients who use immunosuppressive agents for the treatment of a variety of disorders, including gastrointestinal, dermatologic, neurologic and rheumatologic, among others.
Among these is the B.1.1.7 SARS-CoV-2 variant, with its characteristic N501Y mutation. A new preprint on the bioRxiv server reports the impact of this mutation on CD4 T cell responses, including antigen presentation on cells expressing Major Histocompatibility Complex (MHC) class II molecules.
A shorter course of androgen suppression therapy prior to radiation therapy, when compared to a longer course of androgen suppression therapy, yields favorable outcomes and fewer adverse effects for intermediate-risk prostate cancer patients, according to research presented today at the American Society for Radiation Oncology's (ASTRO) 55th Annual Meeting.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mia Miller, 3401 S Kelley Ave, Sioux Falls, SD 57106-6300 Ph: (605) 941-7079 | Mia Miller, 550 W Burnsville Pkwy Ste 201, Burnsville, MN 55337-2504 Ph: (605) 274-0217 |
News Archive
Massachusetts General Hospital investigators have found the probable mechanism underlying a previously described biomarker associated with the risk of developing serious diseases ranging from cancer to cardiovascular disease and the risk of serious complications. In a paper published in the American Journal of Hematology, the research team reports finding that higher levels of a measure routinely taken as part of the complete blood count - the extent of variation in the size of red blood cells - is caused by reduced clearance of aging cells from the bloodstream.
Long-term immunosuppressive therapy can cause the hepatitis B virus (HBV) to become active, even in patients who are not aware that they are infected with the virus. A new guideline from the American Gastroenterological Association provides guidance to physicians and patients who use immunosuppressive agents for the treatment of a variety of disorders, including gastrointestinal, dermatologic, neurologic and rheumatologic, among others.
Among these is the B.1.1.7 SARS-CoV-2 variant, with its characteristic N501Y mutation. A new preprint on the bioRxiv server reports the impact of this mutation on CD4 T cell responses, including antigen presentation on cells expressing Major Histocompatibility Complex (MHC) class II molecules.
A shorter course of androgen suppression therapy prior to radiation therapy, when compared to a longer course of androgen suppression therapy, yields favorable outcomes and fewer adverse effects for intermediate-risk prostate cancer patients, according to research presented today at the American Society for Radiation Oncology's (ASTRO) 55th Annual Meeting.
› Verified 5 days ago
Salma Shaker, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 14101 Fairview Dr, Burnsville, MN 55337 Phone: 952-993-3282 | |
Lizbeth Lynne Thomas, DO Surgery Medicare: Medicare Enrolled Practice Location: 303 E Nicollet Blvd, Suite 300, Burnsville, MN 55337 Phone: 952-435-4140 Fax: 952-435-4189 | |
Dr. Elizabeth Gross Gavin, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 550 W Burnsville Pkwy Ste 201, Burnsville, MN 55337 Phone: 763-299-8346 Fax: 605-275-6398 | |
Casey Yang, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 303 E Nicollet Blvd Ste 300, Burnsville, MN 55337 Phone: 612-937-5762 | |
Douglas F. Bailey, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 303 E Nicollet Blvd, Suite 300, Burnsville, MN 55337 Phone: 952-435-4140 Fax: 952-435-4189 | |
Cody John Pratt, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 303 E Nicollet Blvd Ste 300, Burnsville, MN 55337 Phone: 952-435-4189 | |
Nancy L. Guttormson, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 303 E Nicollet Blvd, Suite 300, Burnsville, MN 55337 Phone: 952-435-4140 Fax: 952-435-4189 |